Insider Transactions in Q2 2025 at Prime Medicine, Inc. (PRME)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$42,000
$2.16 P/Share
|
|
Jun 16
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.49 P/Share
|
|
Jun 11
2025
|
David R. Liu > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
21,000
+0.1%
|
$21,000
$1.6 P/Share
|
|
May 21
2025
|
Ann L. Lee Chief Technical Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$100,000
$1.13 P/Share
|
|
May 21
2025
|
Allan Reine Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
125,000
+50.0%
|
$125,000
$1.18 P/Share
|
|
May 20
2025
|
Richard Brudnick Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.19 P/Share
|